Related references
Note: Only part of the references are listed.Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination
Helen R. Wagstaffe et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial
Liriye Kurtovic et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
Damien Friel et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
Alexandra Schafer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R. Barrett et al.
NATURE MEDICINE (2021)
Antibody-mediated complement activation in pathology and protection
Benjamin S. Goldberg et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination
Carolyn M. Boudreau et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein
Fatima Amanat et al.
JOURNAL OF VIROLOGY (2020)
Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults
Hillary A. Vanderven et al.
VACCINE (2020)
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Thach H. Chu et al.
PLOS PATHOGENS (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
Barbara K. Felber et al.
CELL REPORTS (2020)
An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques
Rebecca L. Powell et al.
JOURNAL OF VIROLOGY (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo
Pengfei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination
Todd J. Suscovich et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies
Marina Tuyishime et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om et al.
PLOS PATHOGENS (2020)
Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection
Delphine C. Malherbe et al.
NPJ VACCINES (2020)
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
Cathrine Scheepers et al.
CELL REPORTS (2020)
The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
Bronwyn M. Gunn et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
Mark J. Bailey et al.
MBIO (2019)
Outflanking immunodominance to target subdominant broadly neutralizing epitopes
Davide Angeletti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
Andrew R. Crowley et al.
FRONTIERS IN IMMUNOLOGY (2019)
Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
George K. Lewis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Differential requirements for FcγR engagement by protective antibodies against Ebola virus
Stylianos Bournazos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk
Scott D. Neidich et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
Anna Z. Wec et al.
CELL HOST & MICROBE (2019)
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
Luca Schifanella et al.
PLOS PATHOGENS (2019)
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
Simone I. Richardson et al.
PLOS PATHOGENS (2019)
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
Julie M. Fox et al.
SCIENCE IMMUNOLOGY (2019)
Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults
Hillary A. Vanderven et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC
Matthew J. Worley et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
Shakti Singh et al.
JOURNAL OF VIROLOGY (2018)
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions
Cody S. Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
Preetha Balasubramanian et al.
SCIENTIFIC REPORTS (2018)
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
Simone I. Richardson et al.
PLOS PATHOGENS (2018)
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
Rhea N. Coler et al.
NPJ VACCINES (2018)
Measuring the ability of HIV-specific antibodies to mediate trogocytosis
Simone I. Richardson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
Margaret E. Ackerman et al.
NATURE MEDICINE (2018)
Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever
Tiago Abreu-Mota et al.
NATURE COMMUNICATIONS (2018)
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
Giuseppe Lofano et al.
SCIENCE IMMUNOLOGY (2018)
Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model
James Duehr et al.
JOURNAL OF VIROLOGY (2017)
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144
Lautaro G. Perez et al.
PLOS ONE (2017)
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Taia T. Wang et al.
SCIENCE (2017)
Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults
Fernanda Ana-Sosa-Batiz et al.
VACCINE (2017)
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Todd Bradley et al.
NATURE COMMUNICATIONS (2017)
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs
Joseph R. Francica et al.
BLOOD ADVANCES (2017)
Fc functional antibodies in humans with severe H7N9 and seasonal influenza
Hillary A. Vanderven et al.
JCI INSIGHT (2017)
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J. Henry Dunand et al.
CELL HOST & MICROBE (2016)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge
Sinthujan Jegaskanda et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine
Anne B. Kristensen et al.
JOURNAL OF VIROLOGY (2016)
The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
Sidhartha Chaudhury et al.
MALARIA JOURNAL (2016)
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Monica Vaccari et al.
NATURE MEDICINE (2016)
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
Wenqian He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay et al.
PLOS PATHOGENS (2016)
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman et al.
PLOS PATHOGENS (2016)
Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans
Weimin Zhong et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Influenza-Specific Antibody-Dependent Phagocytosis
Fernanda Ana-Sosa-Batiz et al.
PLOS ONE (2016)
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
Christopher D. Petro et al.
JCI INSIGHT (2016)
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Taia T. Wang et al.
CELL (2015)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Dan H. Barouch et al.
SCIENCE (2015)
Antibody-Dependent Cellular Inhibition Is Associated With Reduced Risk Against Febrile Malaria in a Longitudinal Cohort Study Involving Ghanaian Children
Regis W. Tiendrebeogo et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity in Intravenous Immunoglobulin as a Potential Therapeutic Against Emerging Influenza Viruses
Sinthujan Jegaskanda et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Type I and type II Fc receptors regulate innate and adaptive immunity
Andrew Pincetic et al.
NATURE IMMUNOLOGY (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
Fumihiko Yasui et al.
VIROLOGY (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques
Brian Moldt et al.
JOURNAL OF VIROLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunoglobulin class-switch DNA recombination: induction, targeting and beyond
Zhenming Xu et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus
Jae-Min Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndrome
FF Yuan et al.
TISSUE ANTIGENS (2005)
The generation of antibody diversity through somatic hypermutation and class switch recombination
ZQ Li et al.
GENES & DEVELOPMENT (2004)
Share Paper
